Market Cap
€113.84 Billion
EUR as of July 1, 2024
US$122.28 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
AbbVie | $295.34 B |
AstraZeneca | $236.45 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Sanofi, along with its subsidiaries, is involved in the research, development, manufacture, and marketing of various therapeutic solutions. It operates in three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. It offers a wide range of products for specialty care, diabetes, cardiovascular issues, and provides vaccines for various diseases, consumer healthcare products, wellness, probiotics, digestive, and nutritional products.
Sanofi has the following listings and related stock indices.
Stock: Euronext: SAN
Stock: BMV: SNYN
Stock: FSX: SNW
Stock: FSX: SNW2
Stock: MTA: SANF
Stock: OTC: SNYNF
Stock: NASDAQ: SNY
Stock: XETR: SNW
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.